Stephen Machatha insider trades
Open-market stock purchases and sales by Stephen Machatha, Chief Development Officer at Aldeyra Therapeutics, Inc, from SEC Form 4 filings since Apr 12, 2021.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- ALDX Aldeyra Therapeutics, Inc: 5 sales, last Aug 11, 2025